Autolus Therapeutics Plc (AUTL)
1.81
-0.10
(-5.24%)
USD |
NASDAQ |
Jan 09, 16:00
1.84
+0.03
(+1.66%)
After-Hours: 07:34
Autolus Therapeutics Research and Development Expense (Annual): 118.79M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 6.679M |
| NuCana Plc | 23.02M |
| Mereo BioPharma Group Plc | 20.94M |
| Bicycle Therapeutics Plc | 216.26M |
| Adaptimmune Therapeutics Plc | 160.54M |